Unichem Pharmaceuticals Recalls Cyclobenzaprine Tablets Due to Labeling Error
Unichem Pharmaceuticals recalled 230 bottles of Cyclobenzaprine Hydrochloride Tablets on August 27, 2025. The recall stems from a labeling mix-up with Meloxicam tablets, which could lead to serious health risks. Consumers should stop using the product immediately and contact their healthcare provider.
Quick Facts at a Glance
Recall Date
August 27, 2025
Hazard Level
HIGH
Brands
CYCLOBENZAPRINE HYDROCHLORIDE, Unichem Pharmaceuticals (USA), Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Unichem Pharmaceuticals USA Inc. or your healthcare provider for guidance. Notification method: Press Release
Product Details
The recalled product is Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, in 90-count bottles. It was manufactured by Unichem Laboratories, Ltd. and distributed nationwide in the USA.
The Hazard
The recall was initiated due to a labeling error that mixed up Cyclobenzaprine Hydrochloride Tablets with Meloxicam USP, 7.5 mg tablets. This mix-up poses a risk of patients receiving the wrong medication, which could lead to adverse health effects.
Reported Incidents
As of the recall date, no injuries have been reported. However, the potential for misuse of the medication due to labeling confusion remains a serious concern.
What to Do
Consumers should stop using the recalled tablets immediately. Contact Unichem Pharmaceuticals USA Inc. or your healthcare provider for further guidance and information on returning the product.
Contact Information
For further assistance, consumers can reach Unichem Pharmaceuticals at their official website or by calling customer service.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.